References
- Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. Ergosterol biosynthesis pathway in Aspergillus fumigatus. Steroids. 2008 Mar;73(3):339–347. https://doi.org/10.1016/j.steroids.2007.11.005
- Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW. Interrogation of related clinical panazole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother. 2011 Nov; 55(11):5113–5121. https://doi.org/10.1128/AAC.00517-11
- Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997 Sep; 25(17):3389–3402. https://doi.org/10.1093/nar/25.17.3389
- Arikan-Akdagli S, Ghannoum M, Meis JF. Antifungal resistance: Specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus. J Fungi. 2018 Dec; 4(4):129. https://doi.org/10.3390/jof4040129
- Baranyi N, Kocsubé S, Jakšić Despot D, Šegvić Klarić M, Szekeres A, Bencsik O, Kecskeméti A, Manikandan P, et al. Combined genotyping strategy reveals structural differences between Aspergillus flavus lineages from different habitats impacting human health. J Basic Microbiol. 2017 Nov;57(11):899–909. https://doi.org/10.1002/jobm.201700243
- Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(W1):W252–W258. https://doi.org/10.1093/nar/gku340
- Buil JB, Zoll J, Verweij PE, Melchers WJG. Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples. Front Microbiol. 2018 Mar;9:515. https://doi.org/10.3389/fmicb.2018.00515
- Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature. Antimicrob Agents Chemother. 2012 Jan;56(1):10–16. https://doi.org/10.1128/AAC.05088-11
- Celia-Sanchez BN, Mangum B, Brewer M, Momany M. Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi. G3 Genes Genomes Genet. 2022 Nov;12(11):jkac249. https://doi.org/10.1093/g3journal/jkac249
- Chen J, Li H, Li R, Bu D, Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005 Jan;55(1):31–37. https://doi.org/10.1093/jac/dkh507
- Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017 Aug;216(suppl_3):S436–S444. https://doi.org/10.1093/infdis/jix210
- Da Silva Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MHS, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol. 2005 Jan;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114
- de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padín-González C, Burger E, Badali H, Richard-Yegres N, van den Ende AH. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007;58:219–34. https://doi.org/10.3114/sim.2007.58.08
- Denning DW, Perlin DS. Azole resistance in Aspergillus: A growing public health menace. Future Microbiol. 2011 Nov;6(11):1229–32. https://doi.org/10.2217/fmb.11.118
- Espinel-Ingroff A, Turnidge J. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds. Rev Iberoam Micol. 2016 Apr-Jun;33(2):63–75. https://doi.org/10.1016/j.riam.2016.04.001
- Fattahi A, Zaini F, Kordbacheh P, Rezaie S, Safara M, Fateh R, Farahyar S, Kanani A, Heidari M. Evaluation of mRNA expression levels of cyp51A and mdr1, candidate genes for voriconazole resistance in Aspergillus flavus. Jundishapur J Microbiol. 2015; 8(12): e26990. https://doi.org/10.5812/jjm.26990
- Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MH, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus. Med Mycol. 2005 May;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114
- Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. J Antimicrob Chemother. 2015 Oct;70(10):2894–2898. https://doi.org/10.1093/jac/dkv177
- Furukawa T, van Rhijn N, Fraczek M, Gsaller F, Davies E, Carr P, Gago S, Fortune-Grant R, Rahman S, Gilsenan JM, et al. The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus. Nat Commun. 2020 Jan;11(1):427. https://doi.org/10.1038/s41467-019-14191-1
- Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005 May;49(5):2119–2121. https://doi.org/10.1128/AAC.49.5.2119-2121.2005
- Gonzalez-Jimenez I, Lucio J, Amich J, Cuesta I, Sanchez Arroyo R, Alcazar-Fuoli L, Mellado E. A Cyp51B mutation contributes to azole resistance in Aspergillus fumigatus. J Fungi. 2020 Nov;6(4):315. https://doi.org/10.3390/jof6040315
- Hadrich I, Makni F, Neji S, Abbes S, Cheikhrouhou F, Trabelsi H, Sellami H, Ayadi A. Invasive aspergillosis: Resistance to antifungal drugs. Mycopathologia. 2012a Aug;174(2):131–141. https://doi.org/10.1007/s11046-012-9526-y
- Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, Ayadi A, Ranque S. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012b Nov; 50(8):829–834. https://doi.org/10.3109/13693786.2012.684154
- Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, Hdiji S, Elloumi M, Ayadi A. Invasive aspergillosis: Epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses. 2010 Sep;53(5):443–447. https://doi.org/10.1111/j.1439-0507.2009.01710.x
- Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus Fungi. Front Microbiol. 2016 Sep;7:1382. https://doi.org/10.3389/fmicb.2016.01382
- Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ, Schotzinger RJ, York JD, Guengerich FP, Lepesheva GI. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem. 2017a Apr;292(16): 6728–6743. https://doi.org/10.1074/jbc.M117.778308
- Hargrove TY, Garvey EP, Hoekstra WJ, Yates CM, Wawrzak Z, Rachakonda G, Villalta F, Lepesheva GI. Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14α-demethylase provides insights into its broad-spectrum antifungal activity. Antimicrob Agents Chemother. 2017b Jun;61(7):e00570-17. https://doi.org/10.1128/AAC.00570-17
- Hawkins NJ, Cools HJ, Sierotzki H, Shaw MW, Knogge W, Kelly SL, Kelly DE, Fraaije BA. Paralog re-emergence: A novel, historically contingent mechanism in the evolution of antimicrobial resistance. Mol Biol Evol. 2014 Jul;31(7):1793–1802. https://doi.org/10.1093/molbev/msu134
- Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology. 2007 Jun;153(6):1677–1692. https://doi.org/10.1099/mic.0.2007/007641-0
- Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection. Med Mycol. 2011 Apr;49(Suppl_1):S90–S95. https://doi.org/10.3109/13693786.2010.508469
- Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009 Jul;15(7):1068–1076. https://doi.org/10.3201/eid1507.090043
- Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect. 2010 Jun;16(6):683–688. https://doi.org/10.1111/j.1469-0691.2009.02911.x
- Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007 May;23(10): 1289–1291. https://doi.org/10.1093/bioinformatics/btm091
- Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 2008 Dec; 32(6): 519–524. https://doi.org/10.1016/j.ijantimicag.2008.06.018
- Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus. Diagn Microbiol Infect Dis. 2012 Nov;74(3):272–277. https://doi.org/10.1016/j.diagmicrobio.2012.06.030
- Lescar J, Meyer I, Akshita K, Srinivasaraghavan K, Verma C, Palous M, Mazier D, Datry A, Fekkar A. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. J Antimicrob Chemother. 2014 Dec;69(12):3244–3247. https://doi.org/10.1093/jac/dku316
- Liu W, Sun Y, Chen W, Liu W, Wan Z, Bu D, Li R. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis. Antimicrob Agents Chemother. 2012 May;56(5):2598–603. https://doi.org/10.1128/AAC.05477-11
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT Method. Methods. 2001 Dec;25(4):402–408. https://doi.org/10.1006/meth.2001.1262
- Lucio J, Gonzalez-Jimenez I, Rivero-Menendez O, Alastruey-Izquierdo A, Pelaez T, Alcazar-Fuoli L, Mellado E. Point mutations in the 14-α sterol demethylase Cyp51A or Cyp51C could contribute to azole resistance in Aspergillus flavus. Genes. 2020 Oct; 11(10):1217. https://doi.org/10.3390/genes11101217
- Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother. 2003 Feb;47(2):577–81. https://doi.org/10.1128/AAC.47.2.577-581.2003
- Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ. FireDock: A web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008 Jul;36(suppl_2): W229–W232. https://doi.org/10.1093/nar/gkn186
- Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. Infect Dis Now. 2021 Nov;51(8): 654–660. https://doi.org/10.1016/j.idnow.2021.04.002
- Mellado E, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility. Antimicrob Agents Chemother. 2011 Dec;55(12):5459–5468. https://doi.org/10.1128/AAC.05178-11
- Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol. 2001 Jul;39(7):2431–2438. https://doi.org/10.1128/JCM.39.7.2431-2438.2001
- Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004 Jul;48(7):2747–2750. https://doi.org/10.1128/AAC.48.7.2747-2750.2004
- Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O’Connell JD 3rd, Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, et al. Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci USA. 2014 Mar;111(10):3865–3870. https://doi.org/10.1073/pnas.1324245111
- Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother. 2003 May;47(5):1719–1726. https://doi.org/10.1128/AAC.47.5.1719-1726.2003
- Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, Berriman M, Abe K, Archer DB, Bermejo C, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature. 2005 Dec;438(7071):1151–6. https://doi.org/10.1038/nature04332
- Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug;63(4):e1–e60. https://doi.org/10.1093/cid/ciw326
- Paul RA, Rudramurthy SM, Meis JF, Mouton JW, Chakrabarti A. A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus. Antimicrob Agents Chemother. 2015 Oct; 59(10):6615–6619. https://doi.org/10.1128/AAC.00637-15
- Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022 May;7(5):663–674. https://doi.org/10.1038/s41564-022-01091-2
- Sagatova AA, Keniya MV, Wilson RK, Monk BC, Tyndall JD. Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14α-demethylase. Antimicrob Agents Chemother. 2015 Aug;59(8):4982–9. https://doi.org/10.1128/AAC.00925-15
- Sharma C, Kumar R, Kumar N, Masih A, Gupta D, Chowdhary A. Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India. Antimicrob Agents Chemother. 2018 Feb;62(3):e01928–17. https://doi.org/10.1128/AAC.01928-17
- Shelton JMG, Rhodes J, Uzzell CB, Hemmings S, Brackin AP, Sewell TR, Alghamdi A, Dyer PS, Fraser M, Borman AM, et al. Citizen science reveals landscape-scale exposures to multiazoleresistant Aspergillus fumigatus bioaerosols. Sci Adv. 2023 Jul;9(29): eadh8839. https://doi.org/10.1126/sciadv.adh8839
- Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011 Oct;7:539. https://doi.org/10.1038/msb.2011.75
- Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008 Nov;5(11):e219. https://doi.org/10.1371/journal.pmed.0050219
- Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques. 2000 Jun;28(6):1102–1104. https://doi.org/10.2144/00286ir01
- Thenmozhi M, Kannabiran K. Interaction of Streptomyces sp. VITSTK7 compounds with selected antifungal drug target enzymes by in silico molecular docking studies. Interdiscip Sci. 2013 Jun;5(2): 145–149. https://doi.org/10.1007/s12539-013-0163-z
- Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3 – new capabilities and interfaces. Nucleic Acids Res. 2012 Aug;40(15):e115. https://doi.org/10.1093/nar/gks596
- Van Rhijn N, Bromley M, Richardson M, Bowyer P. CYP51 paralogue structure is associated with intrinsic azole resistance in fungi. mBio. 2021 Oct 26;12(5):e0194521. https://doi.org/10.1128/mBio.01945-21
- VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques. 2008 Apr;44(5):619–626. https://doi.org/10.2144/000112776
- Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus: A growing public health concern. Curr Opin Infect Dis. 2013 Dec;26(6):493–500. https://doi.org/10.1097/QCO.0000000000000005
- Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus: Can we retain the clinical use of moldactive antifungal azoles? Clin Infect Dis. 2016 Feb;62(3):362–368. https://doi.org/10.1093/cid/civ885